Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Pharmaceuticals Corp (NY: ZOM )

0.1550 +0.0070 (+4.73%)
Official Closing Price Updated: 4:10 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,747,925
Open 0.1508
Bid (Size) 0.1510 (1)
Ask (Size) 0.1546 (3)
Prev. Close 0.1480
Today's Range 0.1506 - 0.1550
52wk Range 0.1200 - 0.2285
Shares Outstanding 979,949,668
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA
Via ACCESSWIRE
Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets
Via ACCESSWIRE

Performance

YTD
-16.49%
-16.49%
1 Month
+6.24%
+6.24%
3 Month
+19.14%
+19.14%
6 Month
+18.14%
+18.14%
1 Year
-26.12%
-26.12%

More News

Read More
7 ‘Lottery Ticket Stocks’ That Could Turn $1K into $10K
Via InvestorPlace
US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians
Via ACCESSWIRE
Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform
Via ACCESSWIRE
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark
Via ACCESSWIRE
Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels
Via ACCESSWIRE
Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay
Via ACCESSWIRE
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
Via ACCESSWIRE
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
Via ACCESSWIRE
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
The 3 Most Undervalued Penny Stocks to Buy in June 2024
Via InvestorPlace
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024
Via ACCESSWIRE
Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference
Via ACCESSWIRE
ZOM Stock Earnings: Zomedica Misses Revenue for Q1 2024
Via InvestorPlace
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
Via ACCESSWIRE
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
Via ACCESSWIRE
Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Via ACCESSWIRE
Clearside Biomedical And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
Zomedica And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
Via ACCESSWIRE
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
Via ACCESSWIRE
Zomedica Corp. (NYSE American: ZOM) Featured in Coverage of the EF Hutton Annual Global Conference
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.